Five insights:
1. Orthopedic and spine sales were $1.9 billion with trauma and extremity products seeing the most revenue at $685 million, according to a news release.
2. Knee sales jumped 12.5 percent year over year with $464 million, and hip sales grew 5.9 percent with $464 million.
3. Stryker’s MedSurg and neurotechnology sales were $2.4 billion, an increase of 10.2 percent year over year.
4. Full-year revenue of $4.3 billion was an 8.1 percent increase year over year.
5. “We delivered solid first-quarter results in the face of a challenging macroeconomic environment,” CEO Kevin Lobo said in the release. “We are encouraged by the steady improvement of surgery volumes and the robust demand for our capital products; however, we expect supply chain challenges to persist for much of the year.”
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
